NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

血液循環動態監控系統的全球市場:各產品 (消耗品、螢幕)、各類型 (侵入性/低侵入性/非侵入性)、各終端用戶 (醫院、診所/門診病人治療中心、居家治療)、各地區的預測 (2023年)

Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023

出版商 MarketsandMarkets 商品編碼 325609
出版日期 內容資訊 英文 150 Pages
訂單完成後即時交付
價格
血液循環動態監控系統的全球市場:各產品 (消耗品、螢幕)、各類型 (侵入性/低侵入性/非侵入性)、各終端用戶 (醫院、診所/門診病人治療中心、居家治療)、各地區的預測 (2023年) Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023
出版日期: 2018年08月20日內容資訊: 英文 150 Pages
簡介

全球血液循環動態監控系統市場,預計2018年達8億5780萬美元,2023年達11億6740萬美元,以6.4%的年複合成長率成長。市場成長的主要原因,是研究活動的活躍和技術創新,創業投資 (VC) 資金的流入,老年人口及心血管疾病、糖尿病等患者的增加,政府的輔助強化等。各終端用戶中,預計診所和門診病人治療中心需求今後將大幅擴大。

本報告提供全球血液循環動態監控系統的市場相關調查,市場背景及市場結構,產品類型種類與概要,各產品區分、類型、終端用戶的市場規模的變化與預測,各地區的趨勢,市場成長的各種影響因素分析,競爭環境與市場佔有率,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
  • 推動市場要素
    • 血液循環動態監控系統的技術進步
      • 微機電(MEMS)
      • HPI (低血壓預測指數) 軟體
    • 血液循環動態監控系統研究的擴大
    • 創業投資 (VC) 資金的流入
    • 心血管疾病、糖尿病的患者增加
    • 老年人口的增加和,手術數量的增加
    • 產業相關人員的知名度提高的配合措施
    • 政府對緊急醫療基礎設施、服務的關心
  • 阻礙市場要素
    • 侵入性血液循環動態監測的相關風險
  • 市場機會
    • 新興國家市場
    • 在醫院以外的病患監測設備的需求增加
  • 課題
    • 市場相關人員的價格壓力的增加
    • 疾病診斷相關患者認識的限制
    • 熟練專家的不足

第6章 血液循環動態監控系統的全球市場:各產品

  • 簡介
  • 消耗品
  • 螢幕

第7章 血液循環動態監控系統的全球市場:各類型

  • 簡介
  • 侵入性血液循環動態監控系統
  • 低侵入性血液循環動態監控系統
  • 非侵入性血液循環動態監控系統

第8章 血液循環動態監控系統的全球市場:各終端用戶

  • 簡介
  • 醫院
  • 診所、門診病人治療中心 (ACC)
  • 家庭治療

第9章 血液循環動態監控系統的全球市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
  • 歐洲 (德國,英國,法國等)
  • 亞太地區 (日本,中國,印度等)
  • 其他國家 (RoW)

第10章 競爭環境

  • 簡介
  • 血液循環動態監控系統的市場佔有率分析
    • EDWARDS LIFESCIENCES CORPORATION
    • PULSION MEDICAL SYSTEMS SE
    • LIDCO GROUP PLC
  • 血液循環動態監控系統的市場佔有率分析:各地區
  • 競爭方案

第11章 企業簡介 (企業概要,服務、組合的擴充度,事業策略的優秀性,跟其他公司的主要關係性)

  • EDWARDS LIFESCIENCES CORPORATION
  • PULSION MEDICAL SYSTEMS SE (THE MAQUET GETINGE GROUP的一部分)
  • LIDCO GROUP
  • DELTEX MEDICAL GROUP PLC
  • ICU MEDICAL
  • CNSYSTEMS MEDIZINTECHNIK GMBH
  • CARETAKER MEDICAL
  • OSYPKA MEDICAL GMBH
  • CHEETAH MEDICAL

第12章 附錄

目錄
Product Code: MD 3211

"The hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4% during the forecast period."

The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. Technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, and government focus on critical care infrastructure & services are expected to drive the growth of the hemodynamic monitoring systems market. However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market to a certain extent.

"By product, the monitors segment is expected to grow at the highest rate during the forecast period."

Based on product, the global hemodynamic monitoring systems market is segmented into two broad categories-monitors and disposables. The monitors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of CVDs; technological advancements in monitoring systems; increasing funding by government authorities for improving patient-centered care, safety, and efficiency; and the ability of hemodynamic monitors to improve cath lab efficiency.

"By type, the noninvasive systems segment is expected to grow at the highest rate during the forecast period (2018-2023)."

On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive systems. The noninvasive hemodynamic monitoring systems segment is expected to grow at the highest CAGR during the forecast owing to the benefits it offers such as reduced staffing costs, treatment expenses, and hospital stay. Furthermore, the rising incidence of respiratory disorders; fewer complications of noninvasive hemodynamic monitoring compared to invasive methods, enhanced portability & precision, and ease of use are additional factors driving the growth of this market segment.

"By end user, the clinics and ambulatory care centers segment is expected to grow at the highest rate during the forecast period."

On the basis of end user, the global hemodynamic monitoring systems market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. The clinics and ACCs segment is expected to register the highest CAGR during the forecast period due to the growing number of ambulatory care centers globally, improving reimbursements for ACCs, growing number of patients visiting clinics & ACCs, and increasing number of initiatives by governments.

"The Asia Pacific hemodynamic monitoring systems market is expected to grow at the highest CAGR during the forecast period."

Asia Pacific is expected to witness the highest growth from 2018 to 2023. This high growth rate is attributed to Japan's growing healthcare industry; extensive government reimbursement coverage for critical cardiac procedures; improving healthcare infrastructure in India and China; high diabetes prevalence in Vietnam, Singapore, Malaysia, China, and India; and government initiatives in Australia and Singapore.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 2-25% and Tier 3-20%
  • By Designation - C-level-43%, Director Level-32%, Others-25%
  • By Region - Europe-38%, North America-23%, Asia Pacific-29%, RoW-10%

The key players in the global hemodynamic monitoring systems market are: Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia).

Research Coverage:

The report analyzes the hemodynamic monitoring systems market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the hemodynamic monitoring systems market. The report analyzes the market based on product, type, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the hemodynamic monitoring systems market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring systems across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
    • 1.3.2. MARKETS COVERED
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key Data from Primary Sources
      • 2.1.2.2. Key Industry Insights
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.3. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HEMODYNAMIC MONITORING SYSTEMS MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY AND END USER
  • 4.3. GEOGRAPHIC SNAPSHOT: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET
  • 4.4. GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE (2018 VS. 2023)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Technological advancements in hemodynamic monitoring systems
      • 5.2.1.2. Microelectromechanical Systems (MEMS)
      • 5.2.1.3. Hypotension Prediction Index (HPI) software
      • 5.2.1.4. Increasing research into hemodynamic monitoring systems
      • 5.2.1.5. Influx of VC funding
      • 5.2.1.6. Rising prevalence of cardiovascular diseases and diabetes
      • 5.2.1.7. Rising geriatric population and growing number of surgeries
      • 5.2.1.8. Awareness initiatives by industry players
      • 5.2.1.9. Government focus on critical care infrastructure and services
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Risks associated with invasive hemodynamic monitoring
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Growing demand for patient monitoring devices in non-hospital settings
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Increasing pricing pressure on market players
      • 5.2.4.2. Limited patient awareness related to disease diagnosis
      • 5.2.4.3. Dearth of skilled professionals

6. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. DISPOSABLES
  • 6.3. MONITORS

7. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. INVASIVE HEMODYNAMIC MONITORING SYSTEMS
  • 7.3. MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS
  • 7.4. NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS

8. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. CLINICS AND AMBULATORY CARE CENTERS
  • 8.4. HOME CARE SETTINGS

9. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. ROE
  • 9.4. ASIA PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. ROAPAC
  • 9.5. ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS
    • 10.2.1. EDWARDS LIFESCIENCES CORPORATION
    • 10.2.2. PULSION MEDICAL SYSTEMS SE
    • 10.2.3. LIDCO GROUP PLC
  • 10.3. HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS, BY REGION
  • 10.4. COMPETITIVE SCENARIO

11. COMPANY PROFILES (Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships)*

  • 11.1. EDWARDS LIFESCIENCES CORPORATION
  • 11.2. PULSION MEDICAL SYSTEMS SE (PART OF THE MAQUET GETINGE GROUP)
  • 11.3. LIDCO GROUP
  • 11.4. DELTEX MEDICAL GROUP PLC
  • 11.5. ICU MEDICAL
  • 11.6. CNSYSTEMS MEDIZINTECHNIK GMBH
  • 11.7. CARETAKER MEDICAL
  • 11.8. OSYPKA MEDICAL GMBH
  • 11.9. CHEETAH MEDICAL
  • 11.10. USCOM LIMITED
  • 11.11. NI MEDICAL

*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE: HEMODYNAMIC MONITORING SYSTEMS MARKET
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE HEMODYNAMIC MONITORING SYSTEMS SEGMENT
  • TABLE 2: TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20-79 YEARS), 2015 VS. 2040
  • TABLE 3: POPULATION AGED 60 YEARS AND OVER, BY REGION (IN MILLION)
  • TABLE 4: AWARENESS INITIATIVES IN 2017-2018
  • TABLE 5: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 6: TYPES OF DISPOSABLES USED IN HEMODYNAMIC MONITORING
  • TABLE 7: HEMODYNAMIC MONITORING DISPOSABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: NORTH AMERICA: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 9: EUROPE: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: ASIA PACIFIC: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: TYPES OF HEMODYNAMIC MONITORS
  • TABLE 12: HEMODYNAMIC MONITORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: NORTH AMERICA: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: EUROPE: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 15: ASIA PACIFIC: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 17: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: ASIA PACIFIC: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 24: ASIA PACIFIC: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: ASIA PACIFIC: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 30: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 41: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 45: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 46: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 47: US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 48: US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 50: CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 51: CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 52: CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 53: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 54: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 55: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 57: GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 58: GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 60: UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 61: UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 63: FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 64: FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 65: FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 66: ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 67: ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: PROMINENT RESEARCH PROJECTS FOCUSING ON HEMODYNAMIC MONITORING
  • TABLE 70: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 71: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 72: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 74: JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 75: JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 77: CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 78: CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 79: CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 80: INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 81: INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 82: INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 83: ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 84: ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 85: ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 86: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 87: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 89: PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2015-2018
  • TABLE 90: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
  • TABLE 91: OTHER DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1: HEMODYNAMIC MONITORING SYSTEMS MARKET SEGMENTATION
  • FIGURE 2: HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: MONITORS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 9: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS 2023
  • FIGURE 10: HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018
  • FIGURE 11: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 12: TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING SYTEMS IS THE KEY FACTOR DRIVING THE GROWTH OF THE MARKET
  • FIGURE 13: HOSPITALS SEGMENT TO DOMINATE THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018
  • FIGURE 14: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: INVASIVE SYSTEMS SEGMENT TO COMMAND THE LARGEST MARKET SHARE BY 2023
  • FIGURE 16: PERCENTAGE CHANGE IN POPULATION AGED 60 YEARS AND OVER, BY REGION (2000-2030)
  • FIGURE 17: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 18: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS. 2023
  • FIGURE 19: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 20: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2018 VS. 2023
  • FIGURE 21: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 22: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 23: ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 24: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 25: KEY DEVELOPMENTS IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET BETWEEN 2015 AND 2018
  • FIGURE 26: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 27: NORTH AMERICA: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 28: EUROPE: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 29: ASIA PACIFIC: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 30: ROW: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 31: GEOGRAPHIC PRESENCE OF KEY PLAYERS
  • FIGURE 32: EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 33: PULSION MEDICAL SYSTEMS SE: COMPANY SNAPSHOT (2017)
  • FIGURE 34: LIDCO GROUP: COMPANY SNAPSHOT (2017)
  • FIGURE 35: DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT (2017)
  • FIGURE 36: ICU MEDICAL: COMPANY SNAPSHOT (2017)
  • FIGURE 37: USCOM: COMPANY SNAPSHOT (2017)